University of Illinois chemist Paul Hergenrother developed an anti-cancer drug, PAC-1, that has shown promise for treatment of cancer in dogs at the University of Illinois Veterinary Teaching Hospital. Veterinary oncologist and trial coordinator Tim Fan says the drug was evaluated in dogs who had advanced blood or bone cancers that had metastasized to lung tissue. The drug works by triggering cell death, and researchers plan to evaluate its use for treatment of brain cancer in humans.

Related Summaries